The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
HPV vaccination introduction worldwide and WHO and UNICEF estimates of national HPV immunization coverage 2010–2019
Open accessAbstract
WHO/UNICEF estimates for HPV vaccination coverage from 2010 to 2019 are analyzed against the backdrop of the 90% coverage target for HPV vaccination by 2030 set in the recently approved global strategy for cervical cancer elimination as a public health problem. As of June 2020, 107 (55%) of the 194 WHO Member States have introduced HPV vaccination. The Americas and Europe are by far the WHO regions with the most introductions, 85% and 77% of their countries having already introduced respectively. A record number of introductions was observed in 2019, most of which in low- and middle- income countries (LMIC) where access has been limited. Programs had an average performance coverage of around 67% for the first dose and 53% for the final dose of HPV. LMICs performed on average better than high- income countries for the first dose, but worse for the last dose due to higher dropout. Only 5 (6%) countries achieved coverages with the final dose of more than 90%, 22 countries (21%) achieved coverages of 75% or higher while 35 (40%) had a final dose coverage of 50% or less. When expressed as world population coverage (i.e., weighted by population size), global coverage of the final HPV dose for 2019 is estimated at 15%. There is a long way to go to meet the 2030 elimination target of 90%. In the post-COVID era attention should be paid to maintain the pace of introductions, specially ensuring the most populous countries introduce, and further improving program performance globally.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Drolet, M., Bénard, É., Pérez, N., Brisson, M., Ali, H., Boily, M.-C., Baldo, V., Brassard, P., Brotherton, J. M. L., Callander, D., et al. (2019) · The Lancet · doi:10.1016/s0140-6736(19)30298-3 · Cited by 1,384
Brisson, M., Kim, J. J., Canfell, K., Drolet, M., Gingras, G., Burger, E. A., Martin, D., Simms, K. T., Bénard, É., Boily, M.-C., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30068-4 · Cited by 1,138
Self-citationBruni, L., Diaz, M., Barrionuevo-Rosas, L., Herrero, R., Bray, F., Bosch, F. X., de Sanjosé, S., & Castellsagué, X. (2016) · The Lancet Global Health · doi:10.1016/s2214-109x(16)30099-7 · Cited by 824
Self-citation(2013) · Vaccine · doi:10.1016/j.vaccine.2013.02.015 · Cited by 551
WHO and UNICEF estimates of national infant immunization coverage: methods and processes
Burton, A. (2009) · Bulletin of the World Health Organization · doi:10.2471/blt.08.053819 · Cited by 422
Immunization agenda 2030: A global strategy to leave no one behind
(2024) · Vaccine · doi:10.1016/j.vaccine.2022.11.042 · Cited by 372
Human papillomavirus vaccines: WHO position paper
WHO (2009) · Biologicals · doi:10.1016/j.biologicals.2009.04.005 · Cited by 357
Human papillomavirus vaccines: WHO position paper, May 2017–Recommendations
(2017) · Vaccine · doi:10.1016/j.vaccine.2017.05.069 · Cited by 352
Turner, N. (2009) · PubMed · Cited by 306
Achieving high coverage in Rwanda’s national human papillomavirus vaccination programme
Binagwaho, A., Wagner, C., Gatera, M., Karema, C., Nutt, C., & Ngaboa, F. (2012) · Bulletin of the World Health Organization · doi:10.2471/blt.11.097253 · Cited by 275
Status of HPV vaccine introduction and barriers to country uptake
Gallagher, K. E., LaMontagne, D. S., & Watson-Jones, D. (2018) · Vaccine · doi:10.1016/j.vaccine.2018.02.003 · Cited by 247
Self-citationHuman papillomavirus vaccines: WHO position paper, October 2014.
(2014) · PubMed · Cited by 205
Who, 。. (2010) · Biologicals · doi:10.1016/j.biologicals.2009.12.007 · Cited by 147
Progress in HPV vaccination in low‐ and lower‐middle‐income countries
LaMontagne, D. S., Bloem, P. N., Brotherton, J. M. L., Gallagher, K. E., Badiane, O., & Ndiaye, C. (2017) · International Journal of Gynecology & Obstetrics · doi:10.1002/ijgo.12186 · Cited by 103
Self-citationPerformance of 21 HPV vaccination programs implemented in low and middle-income countries, 2009–2013
Ladner, J., Besson, M.-H., Rodrigues, M., Audureau, É., & Saba, J. (2014) · BMC Public Health · doi:10.1186/1471-2458-14-670 · Cited by 86
Monitoring of human papillomavirus vaccination
Dillner, J., Arbyn, M., Unger, E. R., & Dillner, L. (2010) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2010.04268.x · Cited by 66
Human papillomavirus vaccine coverage in Rwanda: A population-level analysis by birth cohort
Sayinzoga, F., Umulisa, M. C., Sibomana, H., Tenet, V., Baussano, I., & Clifford, G. M. (2020) · Vaccine · doi:10.1016/j.vaccine.2020.04.021 · Cited by 66
Vänskä, S., Luostarinen, T., Baussano, I., Apter, D. L., Eriksson, T., Natunen, K., Nieminen, P., Paavonen, J. A., Pimenoff, V. N., Pukkala, E., et al. (2020) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiaa099 · Cited by 64
Lehtinen, M., Baussano, I., Paavonen, J. A., Vänskä, S., & Dillner, J. (2019) · Expert Review of Vaccines · doi:10.1080/14760584.2019.1568876 · Cited by 57
Kallenberg, J., Mok, W., Newman, R. D., Nguyen, A., Ryckman, T. S., Saxenian, H., & Wilson, P. (2016) · Health Affairs · doi:10.1377/hlthaff.2015.1079 · Cited by 54
Global Delivery of Human Papillomavirus Vaccines
Wigle, J., Fontenot, H. B., & Zimet, G. D. (2015) · Pediatric Clinics of North America · doi:10.1016/j.pcl.2015.08.004 · Cited by 35
Cited by
Integrative oncology: Addressing the global challenges of cancer prevention and treatment
Mao, J. J., Pillai, G. G., Andrade, C. J., Ligibel, J. A., Basu, P., Cohen, L., Khan, I. A., Mustian, K. M., Puthiyedath, R., Dhiman, K. S., et al. (2022) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21706 · Cited by 446
Bruni, L., Albero, G., Rowley, J., Alemany, L., Arbyn, M., Giuliano, A. R., Markowitz, L. E., Broutet, N., & Taylor, M. (2023) · The Lancet Global Health · doi:10.1016/s2214-109x(23)00305-4 · Cited by 322
Self-citationBasu, P., Malvi, S. G., Joshi, S., Bhatla, N., Muwonge, R., Lucas, E., Verma, Y., Esmy, P. O., Poli, U. R. R., Shah, A., et al. (2021) · The Lancet Oncology · doi:10.1016/s1470-2045(21)00453-8 · Cited by 272
Efficacy of Single-Dose Human Papillomavirus Vaccination among Young African Women
Barnabas, R. V., Brown, E. R., Onono, M. A., Bukusi, E. A., Njoroge, B., Winer, R. L., Galloway, D. A., Pinder, L. F., Donnell, D., Wakhungu, I., et al. (2022) · NEJM Evidence · doi:10.1056/evidoa2100056 · Cited by 223
Drolet, M., Laprise, J.-F., Martin, D., Jit, M., Bénard, É., Gingras, G., Boily, M.-C., Alary, M., Baussano, I., Hutubessy, R., et al. (2021) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30860-4 · Cited by 99
Metadata
- Authors
- Bruni, L., Saura-Lázaro, A., Montoliu, A., Brotons, M., Alemany, L., Diallo, M. S., Afsar, O. Z., LaMontagne, D. S., Mosina, L., Contreras, M., Velandia-González, M., Pastore, R., Gacic-Dobo, M., & Bloem, P.
- Venue
- Preventive Medicine
- Publisher
- Elsevier BV
- Published
- 2021-03
- Volume
- 144
- Pages
- 106399
- ISSN
- 0091-7435 (ISSN-L)
- OpenAlex
- W3116862386
- Cited by
- 758
- References
- 21
- FWCI
- 53.14
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.